PD-1 Inhibitors Enhance Outcomes After CD19 CAR-T
In the ever-evolving landscape of oncology, the search for effective therapeutic strategies against relapsed and refractory non-Hodgkin lymphoma (NHL) remains ...
In the ever-evolving landscape of oncology, the search for effective therapeutic strategies against relapsed and refractory non-Hodgkin lymphoma (NHL) remains ...
Renal cell carcinoma (RCC) presents a formidable challenge in oncology due to its insidious onset and often incidental discovery. Predominantly ...
In breaking new ground in the complex battle against chronic myeloid leukemia (CML), a recent study sheds light on the ...
In the realm of oncology, the landscape of targeted therapies is rapidly evolving. Recent research has illuminated the potential of ...
Lugano, Switzerland, 13 October 2025 – The upcoming ESMO Congress 2025, set to unfold from October 17 to 21 in ...
In a groundbreaking discovery that could reshape therapeutic approaches in oncology, researchers have identified two novel compounds, designated as pyrrole-2,5-dione ...
In a groundbreaking development that could revolutionize colorectal cancer (CRC) treatment, researchers have uncovered a pivotal mechanism underlying cancer stemness ...
In recent years, the landscape of cancer therapy has been revolutionized by innovative approaches that harness the power of the ...
In recent years, cervical cancer has remained a focal point of oncology research, largely due to the remarkable progress made ...
Recent advances in oncology are shedding light on the intricate mechanisms governing cancer progression and metastasis. One particularly striking area ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine